Chronic granulomatous disease (CGD) comprises a heterogeneous group of
inherited conditions characterized biochemically by disordered functi
on of a unique multicomponent enzyme system present in phagocytic cell
s, the NADPH-oxidase. Clinically, it is characterized by recurrent bac
terial and fungal infections that are relatively resistant to treatmen
t by conventional means, Curative bone marrow transplantation has been
successfully achieved in a small number of cases, but the wider appli
cation of this procedure is limited by availability of suitable donor
material. Somatic gene therapy would overcome this problem, and severa
l groups have now shown correction of the biochemical defect in hemato
poietic cells by retrovirus-mediated gene transfer. However, the failu
re of the current generation of retroviral vectors to efficiently tran
sduce quiescent cells greatly restricts their potential for gene trans
fer to pluripotent hematopoietic stem cells. Given these limitations,
we have constructed vectors based on adeno-associated virus and used t
hese to transfer a functional copy of the p47(phox) gene to immortaliz
ed B cells derived from patients with p47(phox)-deficient autosomal re
cessive CGD. We show stable expression of protein and restoration of N
ADPH-oxidase function in these cells in the absence of selection. Aden
oassociated virus vectors may overcome some of the limitations of retr
oviral gene delivery systems and may therefore be a useful vehicle for
curative gene therapy of CGD and other primary immunodeficiencies. (C
) 1995 by The American Society of Hematology.